Vir Biotechnology delays Q2 2022 earnings release to Aug 9, 2022 to finalize results

Vir Biotechnology, Inc.

Company will issue Q2 2022 earnings release on August 9, 2022 after market close.
Delay allows additional time to finalize financial results for the quarter ended June 30, 2022.
Quarterly Report on Form 10-Q remains scheduled for filing on or before its due date of August 9, 2022.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.